Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer

1 Nov 2018

Abstract excerpt

BACKGROUND/AIM: Podocalyxin, a member of the CD34 family of cell surface sialomucins, is overexpressed in human embryonal carcinoma cell lines, as well as in several cancer types, and is associated with poor prognosis. Podocalyxin variants are associated with an increased risk and aggressiveness of prostate cancer. Herein podocalyxin protein expression in prostate cancer was characterized. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Lymphatic System and Diseases
Share to Renal Diseases and Glomerulopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30396958
DOI: 10.21873/anticanres.12994

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate CancerPMID 30396958Read ↗

The TRA-1-60 and TRA-1-81 Human Pluripotent Stem Cell Markers Are Expressed on Podocalyxin in Embryonal CarcinomaSemantic proximity Read ↗

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancerSemantic proximity Read ↗

Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cellsSemantic proximity Read ↗

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.Semantic proximity Read ↗

Oct4A is expressed by a subpopulation of prostate neuroendocrine cellsSemantic proximity Read ↗

Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.Semantic proximity Read ↗

Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cellsSemantic proximity Read ↗

p63 in prostate biology and pathologySemantic proximity Read ↗

PSMA expression on neovasculature of solid tumors.Semantic proximity Read ↗

Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate CancerSemantic proximity Read ↗

Podocalyxin Is a Glycoprotein Ligand of the Human Pluripotent Stem Cell-Specific Probe rBC2LCNSemantic proximity Read ↗

Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.